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Abstract
Objectives—Lactate clearance (LC) and central venous oxygen saturation (ScvO2) have been
proposed as goals of early sepsis resuscitation. The authors sought to determine the agreement and
prognostic value of achieving ScvO2 or LC goals in septic shock patients undergoing emergency
department (ED) based early resuscitation.
Methods—This was a preplanned analysis of a multicenter ED randomized controlled trial of
early sepsis resuscitation targeting three variables: central venous pressure, mean arterial pressure,
and either ScvO2 or LC. Inclusion criteria included suspected infection, two or more systemic
inflammation criteria, and either systolic blood pressure <90 mmHg after intravenous fluid bolus
or lactate > 4 mM. Both ScvO2 and LC were measured simultaneously. The ScvO2 goal was
defined as ≥70%. Lactate was measured at enrollment and every two hours until the goal was
reached, or up to six hours. LC goal was defined as a decrease of ≥ 10% from initial measurement.
The primary outcome was in-hospital mortality.
Results—Two hundred three subjects were included, with an overall mortality of 19.7%.
Achievement of the ScvO2 goal only was associated with a mortality rate of 41% (9/22), while
achievement of the LC goal only was associated with a mortality rate of 8% (2/25; proportion
difference 33%; 95% CI = 9% to 55%). No agreement was found between goal achievement (κ =
−0.02), and exact test for matched pairs demonstrated no significant difference between discordant
pairs (p = 0.78).
Conclusions—No agreement was found between LC and ScvO2 goal achievement in early
sepsis resuscitation. Achievement of a ScvO2 ≥70% without LC ≥10% was more strongly
associated with mortality than achievement of LC ≥10% with failure to achieve ScvO2 ≥70%.
INTRODUCTION
Severe sepsis hospitalizations affect at least 750,000 persons annually in the United
States.1,2 Estimates suggest that 500,000 patients with severe sepsis are treated annually in
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U.S. emergency departments (ED).3 The Surviving Sepsis Campaign (SSC) currently
recommends early structured resuscitation targeting specific values of central venous
pressure, mean arterial pressure, and central venous oxygen saturation (ScvO2).4 While early
quantitative resuscitation protocols have been demonstrated to improve outcomes in patients
with severe sepsis,5-7 there remains significant debate regarding the relative value of early
sepsis resuscitation goals,8,9 particularly the value of ScvO2. Lactate clearance (LC) has
been shown to be non-inferior to ScvO2 as the final goal during early sepsis resuscitation.10
However, to our knowledge no prospective study has directly compared ScvO2 and LC
values measured simultaneously in the same patient during the resuscitative phase of septic
shock.
The need for personnel, training, and equipment for ScvO2 measurement has been cited as a
barrier to implementation for quantitative resuscitation protocols.11 Measurement of LC is
potentially less invasive and requires fewer resources to perform; however, it is still unclear
if these physiologic goals are complimentary or if there is unique value of each as a
resuscitation goal. Our primary aim was to measure the agreement between the achievement
of LC and ScvO2 goals. We also sought to compare the relative prognostic value of
achieving ScvO2 or LC goals in septic shock patients undergoing an early resuscitation
protocol in the ED. Our hypothesis was that there would be very good agreement (κ ≥ 0.8)
between LC and ScvO2 goal achievement, and that attainment of the LC and ScvO2 goals
would have similar ability to predict mortality.
METHODS
Study Design
We conducted a preplanned analysis of a prospective, parallel group randomized clinical
trial designed to assess the non-inferiority of LC versus ScvO2 as the protocol endpoint that
evaluated the adequacy of oxygen delivery during ED-based early quantitative resuscitation
of sepsis. The trial was registered (NCT00372502) and the methods for this study were
published previously.10 The study was approved by the institutional review board at each
institution, and all participants or their surrogate provided written informed consent for
participation.
Study Setting and Population
The trial took place from January 2007 to January 2009 at Carolinas Medical Center,
Charlotte, North Carolina; Beth Israel Deaconess Medical Center, Boston, Massachusetts;
and Cooper University Hospital, Camden, New Jersey, all of which are large, urban,
tertiary-care hospitals staffed by emergency medicine resident physicians supervised by
board certified emergency physicians with established quantitative resuscitation protocols
for severe sepsis. Consecutive patients presenting to one of the participating EDs were
eligible for enrollment if they were older than 17 years, and had confirmed or suspected
infection, two or more systemic inflammatory response criteria,13 and hypoperfusion
evidenced by hypotension after fluid challenge or a blood lactate concentration of at least 4
mmol/L.
Randomization—After enrollment, patients were randomly assigned to one of two
groups. Study group assignment sequence was generated by an independent statistician
using a parallel design, balanced randomization schedule (1:1 ratio of cases and controls).
Study Protocol
Both groups received structured resuscitation in the ED targeting central venous pressure,
mean arterial pressure, and either LC or ScvO2 based on treatment group assignment. The
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study protocol was continued until all endpoints were achieved, or a maximum of six hours.
The published results of this study showed a 6% (95% confidence intervals [CI] = −3% to
14%) in-hospital mortality difference between the two study groups, confirming the primary
hypothesis of non-inferiority between the two resuscitation endpoints.10
Patients assigned to the ScvO2 arm had ScvO2 measurements made using a central venous
catheter capable of continuous ScvO2 measurements (PreSep, Edwards LifeSciences, Irvine,
CA). Patients randomized to the lactate clearance group received an identical central venous
catheter capable of measuring continuous ScvO2. Lactate clearance was defined by the
equation [(lactateinitial –lactatedelayed)/lactateinitial] × 100%, for which lactate initial was the
measurement at the start of the resuscitation, and lactate delayed was another measurement
after a minimum of two hours after resuscitation was initiated. Lactate measurements were
repeated every two hours until the patient met the LC goal, or the six-hour resuscitation
period was complete.
Blinding—As a part of the study protocol, research staff were instructed to perform blinded
measurements of LC if patients were randomized to the ScvO2 arm and blinded ScvO2
measurements if patients were randomized to the LC arm. Blinded lactate and blinded spot
ScvO2 measurements were performed by the research coordinator on a bedside point-of-care
device, and results were printed onto a hard-copy that was immediately gathered by the
research coordinator. Measurements were performed using a deidentified patient ID number,
which did not synchronize with the electronic medical record, and the treating clinicians had
no way to access the data. If the patient was assigned to the LC group, a relative LC was
calculated by the research coordinator and shared with the clinical care providers and at the
same time a spot ScvO2 measurement was performed and was not shared with the clinical
care providers. If the patient was assigned to the ScvO2 group, blinded lactate measurements
were performed, and a LC was calculated. This data was not shared with the clinical care
team, but was recorded on the case report form.
At the suggestion of our hospital regulatory board, the simultaneous blinded measurements
were encouraged, but not mandated, and therefore we expected they would not be performed
on all subjects. Final data analysis was performed on all patients who received both sets of
measurements (Figure 1).
Outcome Measurements
The primary outcome was in-hospital mortality. Patients were categorized based on
achievement of predefined ScvO2 and LC goals. The ScvO2 goal achievement was defined
as ScvO2 ≥70% recorded at any time during the resuscitation. LC goal achievement was
defined as: a) if initial lactate > 2 mM, a decrease of ≥10% from initial; or b) both initial and
repeat levels <2.0 mM. For the purposes of this analysis, patients achieving the ScvO2 or LC
goal at any time point within the 6-hour resuscitation period were considered equivalent.
Data Analysis
Baseline characteristics of included and excluded patients were compared to assess for the
possibility of systematic bias. Baseline characteristics and clinical outcomes of patients
achieving the ScvO2 goal versus those achieving the LC goal were compared using
descriptive analysis. To test if failure to achieve each of these goals has clinical significance,
a subgroup analysis was performed to measure outcome of patients who achieved the ScvO2
goal but not the LC goal, compared with patients who achieved the LC but not the ScvO2
goal.
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Continuous data were tested for normality by Wilks-Shapiro and visual inspection of
histograms. Continuous data are presented as means and standard deviations, or medians and
inter-quartile ranges (IQR) as appropriate. Categorical data are presented as proportions.
Results were compared using t-tests or Mann-Whitney tests for continuous data, and chi-
square or Fisher exact tests for categorical data, as appropriate. We tested for association
between achievement of ScvO2 and lactate clearance goals using Cohen’s kappa, and tested
for differences in discordant pairs using an exact test for matched pairs.12 All statistical tests
were two-sided with p < 0.05 considered significant and no adjustment for multiple
comparisons.
RESULTS
Simultaneous ScvO2 and LC were measured in 203 patients, and 93 patients were excluded
due to lack of concurrent LC and ScvO2 data (Figure 1). Baseline demographics, co-
morbidities, initial vital signs, and percentage of patients achieving the LC or ScvO2 goals
were similar between included and excluded patients, with few exceptions. Excluded
patients were slightly older (63 vs. 59 years, p = 0.047), had a higher incidence of diabetes
mellitus (33% vs. 22%, p = 0.049), and a presented with a lower initial heart rate (97 vs.
108, p = 0.026).
Of the included patients, the median initial ScvO2 was 80% (IQR 74% to 88%), and the
median initial lactate was 3.4 mM (IQR 1.8 to 5.9 mM). The proportion of patients treated
with the LC arm versus the ScvO2 arm of the study was similar (93/203 (46%) vs. 110/203
(54%), percent difference: 8%; 95% CI = −1% to 20%; Figure 1). The ScvO2 goal was
achieved in 175 (86%), and the LC goal was achieved in 178 (88%) patients. Overall in-
hospital mortality rate was 19.7%. Baseline demographics, clinical characteristics,
physiological parameters, and severity of illness variables are shown in Table 1. There were
no differences in co-interventions administered between those patients who achieved the
ScvO2 or LC goals, including transfusion of packed red blood cells or administration of
dobutamine (Table 2).
There was no significant agreement between goal achievement (κ = −0.02, 95% CI = −11.5
to 17.4), with an observed agreement of 76.85% and expected agreement of 77.29%. An
exact test for matched pairs demonstrated no significant difference between discordant pairs
(p = 0.78), suggesting that the discordant pairs were randomly distributed (Table 3). Among
those who met the LC goal, 30 of 178 (17%) died, and among those who met ScvO2 goal,
37 of 175 (21%) died (difference of 4%, 95% CI = −4% to 13%). One hundred fifty-three of
203 subjects met both the ScvO2 and LC goals, and the mortality in this group was 18.3%.
In the subgroup analysis, 22 out of 203 (11%) met only the ScvO2 but not the LC goal, and
25 out of 203 (12%) met only the LC but not the ScvO2 goal. Baseline demographics,
clinical characteristics, physiological parameters, and severity of illness variables between
these subgroups are shown in Table 4. There were no differences in co-interventions
administered between those patients who achieved the ScvO2 or LC goals, including
transfusion of packed red blood cells or administration of dobutamine (Table 5). If the only
the ScvO2 goal (but not the LC goal) was met mortality was 9 of 22 (41%), as opposed to 2
of 25 (8%) if the only the LC goal (but not the ScvO2 goal) was met (proportion difference
33%; 95% CI = 9% to 55%). There were only three patients in which neither goal was met,
one of whom died.
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In this study, we found no significant agreement in the achievement of ScvO2 and LC goals
beyond what would be expected by chance, and also found that achievement of only a
ScvO2 of 70% or more was more strongly associated with mortality than achievement of
only an LC of 10% or more. These data suggest that if only one goal is achieved, failure to
achieve an LC of 10% has a worse prognosis than failure to achieve an ScvO2 of 70%
during early sepsis resuscitation.
Our group recently completed a prospective, parallel group randomized clinical trial
designed to assess the non-inferiority of LC versus ScvO2 as the protocol endpoint to
evaluate the adequacy of oxygen delivery during ED-based early quantitative resuscitation
of sepsis.10 The study demonstrated the non-inferiority of using LC instead of continuous
ScvO2 as the final goal of a resuscitation strategy for septic shock. The current analysis is
unique in that it is the first study of which we are aware in which simultaneous ScvO2 values
and LC measurements were performed in patients undergoing early quantitative
resuscitation for septic shock. Our data suggest that successful achievement of an ScvO2 of
70% or more, but failure to achieve an LC of 10%, is more strongly associated with
mortality in patients with septic shock than is failure to achieve a ScvO2 of 70% or higher
while successfully achieving a lactate clearance of 10% or more. These data represent an
important contribution to the ongoing controversy surrounding the optimal endpoints of
early sepsis resuscitation.
Since the initial adoption of early goal directed therapy as described by Rivers et al.14 into
Surviving Sepsis Campaign recommendations, several implementation studies have
demonstrated reductions in mortality from septic shock.5-7 Despite success associated with
the implementation of the early sepsis quantitative resuscitation, the relative value of
specific resuscitation goals, particularly ScvO2, remain uncertain.8,9 The present study adds
to the available data regarding the relative value of resuscitation goals. Specifically, the
failure to achieve LC during early sepsis resuscitation is associated with higher in-hospital
mortality than failure to achieve ScvO2, suggesting that if a clinician had to choose between
the two goals, LC may be the preferred goal to target.
We found no agreement between ScvO2 and LC goal achievement in this study, suggesting
that these tests may be measuring and/or providing data about physiologically distinct
processes. The physiologic processes measured by ScvO2 and serum lactate are complex,
and are influenced by numerous factors. Generally speaking, however, a decreased ScvO2
results from an imbalance of oxygen consumption and oxygen delivery.15 As oxygen
delivery decreases, in order to maintain consumption and prevent tissue hypoxia, oxygen
extraction increases, resulting in central venous desaturation. This imbalance provides the
rationale for interventions aimed at increasing oxygen supply and decreasing oxygen
demand in patients with low ScvO2. Hyperlactatemia is also well recognized in the setting of
acute infection, and is usually attributed to anaerobic metabolism as a consequence of
hypoperfusion and tissue hypoxia. The true source of hyperlactatemia in sepsis is probably
multi-factorial, and the contribution of catechol-stimulated aerobic lactate production might
be a viable source in some patients.16 This corroborates the clinical observation of
hyperlactatemia in hemodynamically stable patients without clinical evidence of tissue
hypoperfusion, suggesting in some situations that hyperlactatemia is a marker of metabolic
stress rather than true occult hypoperfusion.
LIMITATIONS
This study has several limitations that deserve consideration. First, all three of the hospital
systems have considerable experience with early quantitative resuscitation protocols, and
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our results may not be generalizable to hospitals without such protocols. Second, all
measurements and comparisons of ScvO2 and LC were obtained within the first six hours of
ED resuscitation, and our results may not be generalizable to resuscitation taking place at
later time points in the intensive care unit. Third, treating clinicians had access to either
ScvO2 or LC data based on treatment group assignment, not both, and we do not know how
this additional data may have affected clinical care. Fourth, all patients in this study had
central venous pressure and mean arterial pressure goals targeted prior to ScvO2 or LC
goals. Therefore, we cannot draw any conclusions regarding the relative value of targeting
those goals from this study, nor the value of targeting specific values of ScvO2 or LC in the
absence of central venous pressure and mean arterial pressure optimization. Fifth, while we
did not find a significant difference in the ability of ScvO2 or LC goal achievement to
predict mortality, it is possible that a larger study may result in a different conclusion. Sixth,
we chose in-hospital mortality as an endpoint for this study and it is possible that another
endpoint (such as an organ dysfunction score) may be associated with different results.
Finally, our data can only describe associations and not cause and effect between the
variables and outcomes.
CONCLUSIONS
In septic shock patients treated with an early aggressive resuscitation protocol, we found no
agreement between lactate clearance and central venous oxygen saturation goal
achievement. Achieving central venous oxygen saturation of 70% or more without achieving
a lactate clearance of 10% or more was more strongly associated with mortality than
achievement of a lactate clearance 10% or more with failure to achieve central venous
oxygen saturation of 70% or more.
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Table 1









Age in years, mean (±SD) 59.4 (±17.3) 58.6 (±17.4) 59.8 (±17.6)
Race, n (%)
 White 105 (51.7) 91 (52.0) 90 (50.6)
 Black or African American 80 (39.4) 69 (39.4) 71 (40.0)
 Hispanic 15 (7.4) 13 (7.4) 15 (8.4)
 Other 3 (1.5) 2 (1.1) 2 (1.1)
Sex, n (%)
 Male 110 (54.2) 95 (54.3) 95 (53.4)
 Female 93 (45.8) 80 (45.7) 83 (46.6)
Co-morbidities, n (%)
 Diabetes mellitus 67 (33.0) 53 (30.3) 57 (32.0)
 Chronic obstructive pulmonary disease 33 (16.3) 31 (17.8) 30 (16.9)
 Human immunodeficiency virus 17 (8.4) 16 (9.1) 14 (7.9)
 End stage renal disease 18 (8.9) 17 (9.7) 17 (9.6)
 Active malignancy 52 (25.6) 45 (25.8) 42 (23.6)
 Organ transplant 9 (4.4) 9 (5.1) 8 (4.5)
 Indwelling vascular line 33 (16.3) 23 (13.1) 30 (16.9)
 Nursing home resident 35 (17.2) 28 (13.5) 29 (16.3)
 Do not resuscitate 5 (2.5) 3 (1.7) 5 (2.7)
Disease severity,^ median (IQR)
 SAPS II score 42 (32-56) 42 (31-55) 41 (30-54)
 SOFA score 6 (4-9) 6 (4-9) 6 (4-9)
 MEDS score 11 (8-13) 11 (8-13) 11 (8-13)
Suspected Source of Infection, n (%)
 Pulmonary 69 (33.4) 58 (33.1) 62 (34.8)
 Urinary tract 55 (27.1) 44 (25.1) 49 (27.5)
 Intra-abdominal 34 (16.7) 30 (17.1) 25 (14.0)
 Skin/soft tissue 23 (11.3) 20 (11.4) 21 (11.8)
 Blood 15 (7.4) 14 (8.0) 14 (7.9)
 Unknown 39 (19.2) 36 (20.6) 35 (19.7)
 >1 identified source 28 (13.8) 23 (13.1) 24 (13.5)
Initial physiologic measurements, median (IQR)
 Systolic blood pressure (mmHg) 88 (78-102) 89 (78-103) 90 (79-104)
 Heart rate (beats/minute) 108 (88-122) 109 (87-122) 107 (86-122)
 Respiratory rate (breaths/minute) 22.5 (18-28) 22.5 (18-28) 22 (18-28)
 Glasgow Coma Scale 15 (13-15) 15 (13-15) 15 (13-15)
 Lactate level (mmol/liter) 3.4 (1.8-5.9) 3.4 (1.8-5.9) 3.4 (1.6-6.1)
 Central venous pressure (mmHg) 10 (6-15) 10 (7-14.5) 9 (6-14)






















 ScvO2 80 (74-88) 82 (78-89) 80.5 (74-88)
IQR = interquartile range; SAPS = simple acute physiology score; SOFA = Sequential Organ Failure Assessment; MEDS = Mortality in
Emergency Department Sepsis; ScvO2= central venous oxygen saturation; LC = lactate clearance
^
Disease severity scores calculated at time of enrollment
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Total crystalloid volume (L)* 4.6 (3.0-6.0) 4.6 (3.0-6.0) 4.6 (3.0-6.0)
Parenteral corticosteroids+ 38 (18.7) 35 (20.0) 33 (18.5)
Time to initial antibiotics^ 119 (65-176) 119 (65-185) 117 (63-185)
Mechanical ventilation 65 (32.0) 53 (30.3) 52 (29.2)
Activated Protein C 2 (1.0) 1 (0.6) 2 (1.1)
Dobutamine administered 9 (4.4) 6 (3.4) 8 (4.5)
PRBC administered 10 (4.9) 8 (4.6) 8 (4.5)
Abbreviations: ScvO2 = central venous oxygen saturation; LC = lactate clearance; L = liters;
PRBC = packed red blood cells
Values are reported as either n (%) or median (IQR)
*




Time from ED triage to initiation of antibiotics, in minutes
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Table 3
Concordance between reaching central venous oxygen saturation and lactate clearance goals.
Met LC goal Failed to meet LC
goal
Total
Met ScvO2 goal 153 22 175
Failed to meet ScvO2 goal 25 3 28
Total 178 25 203
ScvO2 = central venous oxygen saturation; LC = lactate clearance
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Age in years, mean (±SD) 1 55.1 (±15.4) 63.9 (±17.0)
Race (%)
 White 13 (59.1) 12 (48.0)
 Black or African American 8 (36.4) 10 (40.0)
 Hispanic 0 (0.0) 2 (8.0)
 Other 1 (4.5) 1 (4.0)
Sex (%)
 Male 12 (54.5) 12 (48)
 Female 10 (44.5) 13 (52)
Co-morbidities (%)
 Diabetes mellitus 8 (36.4) 12 (48.0)
 Chronic obstructive pulmonary disease 3 (13.6) 2(8.0)
 Human immunodeficiency virus 3 (13.6) 1 (4.0)
 End stage renal disease 1 (4.5) 1(4.0)
 Active malignancy 9 (40.9) 6 (24.0)
 Organ transplant 1 (4.5) 0 (0.0)
 Indwelling vascular line 3 (13.7) 10 (40.0)
 Nursing home resident 5 (22.7) 6 (24.0)
 Do not resuscitate 0 (0.0) 2 (8.0)
Disease severity,* median (IQR)
 SAPS II score 53 (35-75) 41 (33-65)
 SOFA score 8 (5-11) 7 (5-9)
 MEDS score 8 (6-13) 11 (9-14)
Suspected Source of Infection (%)
 Pulmonary 6 (27.7) 10 (40.0)
 Urinary tract 6 (27.7) 11 (44.0)
 Intra-abdominal 7 (31.8) 2 (8.0)
 Skin/soft tissue 2 (9.1) 3 (12.0)
 Blood 1 (4.5) 1 (4.0)
 Unknown 4 (18.2) 3 (12.0)
 >1 identified source 4 (18.2) 5 (20.0)
Initial physiologic measurements, median (IQR)
 Systolic blood pressure (mmHg) 73 (67-85) 86 (73-94)
 Heart rate (beats/minute) 111 (95-124) 104 (92-120)
 Respiratory rate (breaths/minute) 24 (20-28) 24 (19-31)
 Glasgow Coma Scale 14 (10-15) 15 (13-15)
 Lactate level (mmol/liter) 3.2 (2.5-5.3) 3.8 (1.9-6.8)




















 Central venous pressure (mmHg) 14 (8-17) 8 (6-14.5)
 ScvO2 81 (77-88) 64 (54-67)
IQR = interquartile range; SAPS = simple acute physiology score; SOFA = Sequential Organ Failure Assessment; MEDS = Mortality in
Emergency Department Sepsis; ScvO2 = central venous oxygen saturation; LC = lactate clearance
*
Disease severity scores calculated at time of enrollment
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Table 5








Total crystalloid volume (L)* 4.7 (3.5-5.9) 4.8 (3.7-5.3)
Parenteral corticosteroids^ 5 (22.7) 3 (12.0)
Time to initial antibiotics*,+ 123 (73-151) 115 (68-140)
Mechanical ventilation 11 (50.0) 10 (40.0)
Activated Protein C 0 (0.0) 1 (4.0)
Dobutamine administered 1 (4.5) 1 (4.0)
PRBC administered 2 (9.1) 4 (16.0)
ScvO2 = central venous oxygen saturation; LC = lactate clearance; L = liters; PRBC = packed red blood cells
Values are reported as either n (%) or median (IQR)
*




Time from emergency department triage to initiation of antibiotics, in minutes
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